Literature DB >> 19344856

The epidemiology of anal human papillomavirus and related neoplasia.

Joel M Palefsky1, Mary Rubin.   

Abstract

The relationship between cervical cancer and human papillomavirus (HPV) is well known. Like cervical cancer, anal cancer is preceded by a series of precancerous changes, raising the possibility that like cervical cancer, anal cancer can be prevented. Further, given the known risk factors for anal cancer, prevention efforts could be targeted to high-risk groups, providing a unique example of a screening program targeted to high-risk individuals. This article describes the epidemiology of anal HPV infection, anal intraepithelial neoplasia, and anal cancer among men and women, as well as current efforts to prevent anal cancers.

Entities:  

Mesh:

Year:  2009        PMID: 19344856     DOI: 10.1016/j.ogc.2009.02.003

Source DB:  PubMed          Journal:  Obstet Gynecol Clin North Am        ISSN: 0889-8545            Impact factor:   2.844


  45 in total

1.  Does framing human papillomavirus vaccine as preventing cancer in men increase vaccine acceptability?

Authors:  Annie-Laurie McRee; Paul L Reiter; Kim Chantala; Noel T Brewer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-07-20       Impact factor: 4.254

Review 2.  Vaccinations for Anal Squamous Cancer: Current and Emerging Therapies.

Authors:  John Berry; Sean C Glasgow
Journal:  Clin Colon Rectal Surg       Date:  2018-11-02

Review 3.  Human papillomavirus disease and vaccines in adolescents.

Authors:  Anna-Barbara Moscicki
Journal:  Adolesc Med State Art Rev       Date:  2010-08

4.  Strategies for screening and early detection of anal cancers: A narrative and systematic review and meta-analysis of cytology, HPV testing, and other biomarkers.

Authors:  Megan A Clarke; Nicolas Wentzensen
Journal:  Cancer Cytopathol       Date:  2018-05-24       Impact factor: 5.284

Review 5.  Anal cancer and intraepithelial neoplasia: epidemiology, screening and prevention of a sexually transmitted disease.

Authors:  Richard J Medford; Irving E Salit
Journal:  CMAJ       Date:  2014-12-15       Impact factor: 8.262

6.  Non-AIDS-Defining Malignancies in the HIV-Infected Population.

Authors:  Chia-Ching J Wang; Michael J Silverberg; Donald I Abrams
Journal:  Curr Infect Dis Rep       Date:  2014-06       Impact factor: 3.725

7.  John Cunningham virus T-antigen expression in anal carcinoma.

Authors:  Sonia Ramamoorthy; Bikash Devaraj; Katsumi Miyai; Linda Luo; Yu-Tsueng Liu; C Richard Boland; Ajay Goel; John M Carethers
Journal:  Cancer       Date:  2010-12-14       Impact factor: 6.860

Review 8.  HPV and anal cancer in HIV-infected individuals: a review.

Authors:  Maarten F Schim van der Loeff; Sofie H Mooij; Oliver Richel; Henry J C de Vries; Jan M Prins
Journal:  Curr HIV/AIDS Rep       Date:  2014-09       Impact factor: 5.071

9.  Beliefs About Anal Cancer among HIV-Infected Women: Barriers and Motivators to Participation in Research.

Authors:  Tracy A Battaglia; Christine M Gunn; Molly E McCoy; Helen H Mu; Amy S Baranoski; Elizabeth Y Chiao; Lisa A Kachnic; Elizabeth A Stier
Journal:  Womens Health Issues       Date:  2015-08-04

10.  Awareness and knowledge of human papillomavirus-related diseases are still dramatically insufficient in the era of high-coverage vaccination programs.

Authors:  Paolo Capogrosso; Eugenio Ventimiglia; Rayan Matloob; Michele Colicchia; Alessandro Serino; Giulia Castagna; Maria Chiara Clementi; Giovanni La Croce; Umberto Capitanio; Giorgio Gandaglia; Rocco Damiano; Vincenzo Mirone; Francesco Montorsi; Andrea Salonia
Journal:  World J Urol       Date:  2014-09-02       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.